Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,801 to 1,820 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of molecular patterns and diagnostic biomarkers in juvenile idiopathic arthritis based on the gene expression of m6A regulators. | Front Pediatr | 2022 | 36160781 | PubTator, text mining | PubMed |
| Exosomes and exosomal miRNAs: A new therapy for intervertebral disc degeneration. | Front Pharmacol | 2022 | 36160436 | PubTator, text mining | PubMed |
| Prognostic analysis of m6A-related lncRNAs as potential biomarkers in intrahepatic cholangiocarcinom. | Front Genet | 2022 | 36160000 | PubTator, text mining | PubMed |
| Identification of clinical prognostic features of esophageal cancer based on m6A regulators. | Front Immunol | 2022 | 36159855 | PubTator, text mining | PubMed |
| METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma. | Front Cell Dev Biol | 2022 | 36158188 | PubTator, text mining | PubMed |
| Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma. | Heliyon | 2022 | 36158075 | PubTator, text mining | PubMed |
| On demand CRISPR-mediated RNA N6-methyladenosine editing. | Genes Dis | 2022 | 36157499 | PubTator, text mining | PubMed |
| Long noncoding RNA XIST: Mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities. | Genes Dis | 2022 | 36157489 | PubTator, text mining | PubMed |
| A bibliometric analysis of RNA methylation in diabetes mellitus and its complications from 2002 to 2022. | Front Endocrinol (Lausanne) | 2022 | 36157472 | PubTator, text mining | PubMed |
| The role of RNA m6A methylation in lipid metabolism. | Front Endocrinol (Lausanne) | 2022 | 36157445 | PubTator, text mining | PubMed |
| Analysis of N6-Methyladenosine RNA Methylation Regulators in Diagnosis and Distinct Molecular Subtypes of Ankylosing Spondylitis. | Dis Markers | 2022 | 36157216 | PubTator, text mining | PubMed |
| Reduced N6-Methyladenosine Mediated by METTL3 Acetylation Promotes MTF1 Expression and Hepatocellular Carcinoma Cell Growth. | Chem Biodivers | 2022 | 36149370 | PubTator, text mining | PubMed |
| Exploring RNA modifications, editing, and splicing changes in hyperuricemia and gout. | Front Med (Lausanne) | 2022 | 36148448 | PubTator, text mining | PubMed |
| A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma. | Front Immunol | 2022 | 36148220 | PubTator, text mining | PubMed |
| Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma. | Front Cell Dev Biol | 2022 | 36147735 | PubTator, text mining | PubMed |
| Autophagy-related Proteins in Genome Stability: Autophagy-Dependent and Independent Actions. | Int J Biol Sci | 2022 | 36147481 | PubTator, text mining | PubMed |
| Role of Epitranscriptomic and Epigenetic Modifications during the Lytic and Latent Phases of Herpesvirus Infections. | Microorganisms | 2022 | 36144356 | PubTator, text mining | PubMed |
| Novel Roles of RNA m6A Methylation Regulators in the Occurrence of Alzheimer's Disease and the Subtype Classification. | Int J Mol Sci | 2022 | 36142676 | PubTator, text mining | PubMed |
| SR Splicing Factors Promote Cancer via Multiple Regulatory Mechanisms. | Genes (Basel) | 2022 | 36140826 | PubTator, text mining | PubMed |
| Slow RNAPII Transcription Elongation Rate, Low Levels of RNAPII Pausing, and Elevated Histone H1 Content at Promoters Associate with Higher m6A Deposition on Nascent mRNAs. | Genes (Basel) | 2022 | 36140819 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=91